HealthStream sells workforce management and credentialing software to hospitals and health systems, including scheduling, competency tracking and credentialing tools used to keep clinical staff compliant and deployed. Its moat comes from being embedded in the daily operations of its customers, where switching means re-validating thousands of clinician credentials and retraining staff, which makes churn sticky. Revenue is growing 12.5% with a 65.1% gross margin, and operating margin of 9.9% shows the business is now converting that growth into profit rather than just spending it. At a 46.9 trailing P/E falling to 33.8 on forward earnings, the market is pricing in continued margin expansion, so the question for a deeper look is whether operating leverage on the existing base can carry the multiple. The 6.0% return on equity and absence of index membership suggest a small, under-followed name where the earnings trajectory matters more than the current print.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 19 Oct 2026, 17:05 CEST | Fair value | $20.54 | $25.58 | $33.13 |
| 19 Oct 2026, 17:05 CEST | Rating | Overvalued | first publication | $33.13 |
| 15 Oct 2026, 00:00 CEST | Fair value | $25.58 | $25.05 | $33.75 |
| 13 Oct 2026, 00:00 CEST | ACCE price target | $32.00 | first publication | $33.13 |
| 10 Oct 2026, 00:00 CEST | Fair value | $25.05 | $24.21 | $32.47 |
| 29 Sept 2026, 00:00 CEST | Fair value | $24.21 | $24.59 | $29.10 |
| 19 Sept 2026, 00:00 CEST | Fair value | $24.59 | $25.96 | $29.19 |
| 16 Sept 2026, 00:00 CEST | Fair value | $25.96 | $26.31 | $29.63 |
| 5 Sept 2026, 00:00 CEST | Fair value | $26.31 | $27.53 | $29.74 |
| 3 Sept 2026, 00:00 CEST | Fair value | $27.53 | $27.04 | $29.67 |
Answered from HealthStream Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| HSTM HealthStream Inc. Common Stock | $35.16 | $21 | 71% above | 46.7x | 6.0% | 71 | 71 |
| TDOC Teladoc Health Inc. Common Stock | $6.34 | - | - | - | -13.0% | 43 | 38 |
| OMDA Omada Health Inc. Common Stock | $18.95 | - | - | 79.1x | 1.8% | 43 | 47 |
| GDRX GoodRx Holdings Inc. Class A Common Stock | $3.54 | $5 | 35% below | 70.8x | 2.5% | 54 | 51 |
| TALK Talkspace Inc. Common Stock | $5.25 | - | - | - | 0.2% | 27 | 52 |
| PHR Phreesia Inc. Common Stock | $12.70 | $16 | 19% below | 74.7x | 3.1% | 55 | 67 |
| CERT Certara Inc. Common Stock | $10.33 | $8 | 22% above | - | -2.2% | 47 | 44 |
Where HSTM ranks against its sector peers on each metric.